Symptom profile and short term outcome of catatonia: An exploratory clinical study

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Worku, Benyam ^a   Fekadu, Abebaw ^a,b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Catatonia; Catatonia syndrome; Ethiopia; Low and middle income country

Indexed keywords

AMITRIPTYLINE; BROMAZEPAM; CLONAZEPAM; DIAZEPAM; FLUOXETINE; IMIPRAMINE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BUSH FRANCIS CATATONIA RATING SCALE; CATATONIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; DEHYDRATION; ELECTROCONVULSIVE THERAPY; ETHIOPIA; EXPLORATORY RESEARCH; FEMALE; HUMAN; HYPOSTATIC PNEUMONIA; MAJOR DEPRESSION; MALE; MUTISM; OBSERVATIONAL STUDY; PNEUMONIA; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; REHYDRATION; SCHIZOPHRENIA; STUPOR; URINARY TRACT INFECTION; COMPLICATION; HOSPITALIZATION; MIDDLE AGED; MOOD DISORDERS; PROGNOSIS; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CATATONIA; ELECTROCONVULSIVE THERAPY; ETHIOPIA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84937684928     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0554-2     Document Type: Article

References (53)

1. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1999;93:129-36.
2. Fink M, Taylor M. The many varieties of catatonia. Eur Arch Psychiatry ClinNeurosci. 2001;251:s8-13.
3. Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatr. 2003;160:1233-41.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA; 1994.
5. Fink M, Taylor M. Signs of Catatonia are Identifiable. In: Catatonia: A Clinician's Guide to Diagnosis and Treatment. New York, NY: Cambridge University Press; 2003. p. 19-32.
6. Fricchione G, Bush G, Fozdar M, Francis A, Fink M. Recognition and treatment of the catatonic syndrome. J Intensive Care Med. 1997;12(3):135-47.
7. Barnes M, Saunders M, Walls T. The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry. 1986;49:991.
8. Stöber G. Genetics. In: Caroff S, Mann S, Francis A, Fricchione G, editors. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press; 2004. p. 173-88.
9. Northoff G. Neuroimaging and Neurophysiology. In: Caroff S, Mann S, Francis A, Fricchione G, editors. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press; 2004. p. 77-92.
10. Northoff G, Steinke R, Czcervenka C, Krause R, Ulrich S, Danos P, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry. 1999;67:445-51.
11. Northoff G, Krill W, Wenke J, Gille B. Major Differences in Subjective Experience of Akinetic States in Catatonic and Parkinsonian Patients. Cognitive neuropsychiatry 1998; 3:161-178.
12. Partl S, Pfuhlmann B, Jabs B. Stöber G: "My disease is one of the mind and difficult to define": Robert Walser (1879-1956) and his mental illness. Nervenarzt. 2011;82(1):67-78.
13. Rosebush P, Hildebrand A, Furlong B, Mazurek M. Catatonic syndrome on a general psychiatric ward: frequency, clinical presentation and response to lorazepam. J Clin Psychiatr. 1990;51:357-62.
14. Johnson J. Catatonia: The tension insanity. Br J Psychiatr. 1993;162:733-8.
15. Kahlbaum K-L. Catatonia or Tonic Insanity. In: Sass H, editor. Anthology of German Psychiatric Texts. Ulm, Germany: World Psychiatric Association; 2007. p. 106-24.
16. Fink M. Rediscovering catatonia, the biography of a treatable syndrome. Acta Psychiatr Scand. 2012;127 Suppl 441:1-47.
17. Fink M, Shorter E, Taylor M. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010;36(2):314-20.
18. Rosebush P, Mazurek M. Catatonia and Its Treatment. Schizophr Bull. 2010;36(2):239-42.
19. Ungvari G, Caroff S, Gerevich J. The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders. Schizophr Bull. 2010;36(2):231-8.
20. Caroff S, Mann S, Campbell E, Sullivan K. Epidemiology. In: Caroff SN MS, Francis A, Fricchione GL, editors. Catatonia: from Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing; 2004. p. 15-31.
21. Morrison J. Catatonia: retarded and excited types. Arch Gen Psychiatry. 1973;28:39-41.
22. Hearst E, Munoz R, Tuason V. Catatonia: its diagnostic validity. Dis Nerv Syst. 1971;32:453-6.
23. Peralta V, Cuesta M. The relationship between syndromes of the psychotic illness and familial liability to schizophrenia and major mood disorders. Schizophr Res. 2007;91(1-3):200-9.
24. Usman D, Olubunmi O, Taiwo O. Comparison of catatonia presentation in patients with schizophrenia and mood disorders in Lagos, Nigeria. Iran J Psychiatry. 2011;6:7-11.
25. Thakur A, Jagadheesan K, Dutta S, Sinhar V. Incidence of catatonia in children and adolescents in a paediatric psychiatric clinic. Aust N Z J Psychiatry. 2003;37:200-3.
26. Leff J. Psychiatry Around the Globe. London: Royal College of Psychiatrists; 1988.
27. Morrison J. Changes in subtype diagnosis of schizophrenia: 1920-1966. Am J Psychiatry. 1974;131(6):674-7.
28. Francis A. Update on catatonia. Psychiatr Times. 2006;23:23-4.
29. Organization WH. The International Pilot Study of Schizophrenia. In. vol. 1. Geneva: World Health Organization; 1973.
30. Hutchinson G, Takei N, Sham P, Harvey I, Murray R. Factor analysis of symptoms in schizophrenia: differences between White and Caribbean patients in Camberwell. Psychol Med. 1999;29(3):607-12.
31. Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales: Cross-cultural comparison of catatonia in new admissions. Psychol Med. 2005;35:1667-75.
32. Ungvari G, Chiu HFK, Chow L, Lau B, Tang W. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999;142:393-8.
33. Berardi D, Amore M, Keck P. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry. 1998;44(8):748-54.
34. Carroll B. Catatonic stupor: diagnosis and treatment. Federal Practitioner 2001;18:48-54.
35. Paparrigopoulos T, Tzavellas E, Ferentinos P. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. World J Biol Psychiatry. 2009;10(1):70-3.
36. Caroff S, Ungvari G, Bhati M, Datto C, O'Reardon J. Catatonia and prediction of response to electroconvulsive therapy. Psychiatr Ann. 2007;37(1):57-64.
37. Hawkins J, Archer K, Strakowski S, Keck PE. Somatic treatment of catatonia. Int J Psychiatry Med. 1995;25:345-369.
38. Levenson J, Pandurangi A. Prognosis and Complications. In: Caroff S, Mann S, Francis A, Fricchione G, editors. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing; 2004. p. 161-72.
39. Fekadu A, Desta M, Alem A, Prince M. A descriptive analysis of admissions to Amanuel Psychiatric Hospital in Ethiopia. Ethiop J Health Dev. 2007;21:173-8.
40. Rajagopal S. Catatonia. Adv Psychiatr Treat. 2007;13:51-9.
41. Abrams R, Taylor M. Catatonia: a prospective clinical study. Arch Gen Psychiatry. 1976;33:579-81.
42. Daniels J. Catatonia: Clinical aspects and neurobiological correlates. J Neuropsychiatr Clin Neurosci. 2009;21:371-80.
43. Lee J, Scwartz D, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to Benzodiazepines. Ann Clin Psychiatry. 2000;12:89-96.
44. Ungvari GA, Leung CM, Wong MK, Lau J. Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand. 1994;89:285-8.
45. Fiedorowicz J, Endicott J, Leon A, Solomon D, Keller M, Coryell W. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry. 2011;168:40-8.
46. Guggenheim F, Babigian H. Catatonic schizophrenia: epidemiology and clinical course. A 7-year register study of 798 cases. J Nerv Ment Dis. 1974;158:291-305.
47. Piccinelli M, Wilkinson G. Gender differences in depression. Crit Rev Br J Psychiatr. 2000;177:486-92.
48. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137-43.
49. World Health Organization. mhGAP Intervention Guide for Mental, Neurological and Substance use Disorders in Non-Specialized Health Settings. Geneva: WHO Press; 2010.
50. Petrides G, Malur C, Fink M. Convulsive Therapy. In: Caroff S, Mann S, Francis A, Fricchione G, editors. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press; 2004. p. 151-60.
51. Fekadu A, Kebede D, Alem A, Fekadu D, Mogga S, Negash A, et al. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia. Acta Psychiatr Scand. 2006;114(6):426-34.
52. Fekadu A, Thornicroft G. Global mental health: perspectives from Ethiopia. Glob Health Action. 2014;7:25447.
53. Moskowitz A. "Scared Stiff": Catatonia as an evolutionary-based fear response. Psychol Rev. 2004;111:984-1002.